15 results
8-K
EX-99.1
VERV
Verve Therapeutics Inc
10 Nov 21
Verve Therapeutics Announces Pipeline Progress and Reports Third Quarter 2021 Financial Results
6:56am
medicines. Backed by an expert team and a strong balance sheet, we stand well positioned to advance our gene editing therapies and fundamentally change
S-1
EX-10.11
cp2dd4aw5dxu66q87
28 May 21
IPO registration
4:04pm
S-1
EX-10.12
1yz078
28 May 21
IPO registration
4:04pm
S-1
EX-10.13
92xl bvoxa
28 May 21
IPO registration
4:04pm
S-1
EX-10.9
8jbr04bgt f6cb
28 May 21
IPO registration
4:04pm
S-1
EX-10.17
4kw4z5lcg l1zf
28 May 21
IPO registration
4:04pm
DRS
EX-10.10
wy015vkxnk
16 Apr 21
Draft registration statement
12:00am
DRS
EX-10.13
zcmk0
16 Apr 21
Draft registration statement
12:00am
DRS
EX-10.12
2jlxr6fffzhe 7ucbr6f
16 Apr 21
Draft registration statement
12:00am
DRS
EX-10.14
ij8j7ggifmpqr28pi
16 Apr 21
Draft registration statement
12:00am
DRS
simry9r9uavoyhndjkc
16 Apr 21
Draft registration statement
12:00am
- Prev
- 1
- Next